ÈËÆÞÖгöÊÓƵ

Regina Rosenthal
( out of 149 reviews )

Regina Rosenthal, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital North

2K, Gynecology and Mammography
Salt Lake City
801-213-4269

Sugar House ÈËÆÞÖгöÊÓƵ Center

Salt Lake City
801-581-2000

  • Dr. Regina Rosenthal is a board-certified general surgeon practicing breast surgery at the ÈËÆÞÖгöÊÓƵ of Utah’s Huntsman Cancer Institute. She has more than twenty years of experience in the surgical treatment of breast cancer. She has been an early advocate for the multidisciplinary approach to breast cancer, which helps tailor treatment plans to the goals and needs of individuals.

    She earned her B.S. degree in biochemistry from The City College of New York and her M.D. from Albert Einstein College of Medicine of Yeshiva ÈËÆÞÖгöÊÓƵ, also in New York. She completed a residency in General Surgery at Boston ÈËÆÞÖгöÊÓƵ Medical Center in Boston, with an additional fellowship year in oncology research. She is board-certified in General Surgery by the American College of Surgeons and is a member of the American Society of Breast Surgeons.

    Dr. Rosenthal has practiced in Salt Lake City since 1991. She practiced all aspects of General Surgery, including trauma and abdominal surgery, until around 2002, when she began to focus her practice on breast cancer. Her practice has been directed exclusively to treating breast cancer and benign breast disease since that time. She is recognized as an early proponent of the team approach to breast cancer care in Salt Lake City.

    Dr. Rosenthal is able to offer a variety of surgical options depending on individual needs, including sentinel lymph node sampling, skin and nipple-sparing mastectomies, and the use of oncoplastic techniques to improve cosmetic results. She is prepared to incorporate reconstructive surgery approaches together with plastic surgeons as part of overall treatment plans. For many patients, more focused rather than more extensive surgery may be a good option. Cooperative presurgical planning with oncology and radiation oncology professionals can expand the range of choices available to individuals with breast cancer.

    Specialties

    Board Certification

    American Board of Surgery

    Patient Rating

    4.9 /5
    ( out of 149 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    July 29, 2024
    HUNTSMAN CANCER CENTER

    I would give Dr. Rosenthal a higher score than "very good" if I could. She has made me feel comfortable calm and well informed. I feel she gave me the best treatment possible. I have been well cared for.

    July 24, 2024
    HUNTSMAN CANCER CENTER

    Dr. Rosenthal is kind and caring. She takes time to carefully communicate and offer options, guidance, and respect for your feelings, choices, and decisions. She listens to you and welcomes your questions and concerns.

    July 24, 2024
    HUNTSMAN CANCER CENTER

    See previous note since it was all about her. She is top notch.

    July 20, 2024
    HUNTSMAN CANCER CENTER

    Dr. Rosenthal is amazing!!!

    July 18, 2024
    HUNTSMAN CANCER CENTER

    Dr. Rosenthal was very good to listen to my concerns in the direction my Cancer seems to be moving. She took time to explain things to me and we ran a few tests to get a better picture of my lump. Those tests will help us figure out which direction to go in my treatment.

    July 18, 2024
    HUNTSMAN CANCER CENTER

    Very attentive.

    July 17, 2024
    HUNTSMAN CANCER CENTER

    Dr Rosenthal is incredible: intelligent, caring, professional.

    July 10, 2024
    HUNTSMAN CANCER CENTER

    Dr. Rosenthal is an amazing doctor that doesn't talk medical jargon but explains everything in a way that I understood.

    June 29, 2024
    HUNTSMAN CANCER CENTER

    Caring and knowledgeable

    See More Patient Comments

  • Dr. Regina Rosenthal is a board-certified general surgeon practicing breast surgery at the ÈËÆÞÖгöÊÓƵ of Utah’s Huntsman Cancer Institute. She has more than twenty years of experience in the surgical treatment of breast cancer. She has been an early advocate for the multidisciplinary approach to breast cancer, which helps tailor treatment plans to the goals and needs of individuals.

    She earned her B.S. degree in biochemistry from The City College of New York and her M.D. from Albert Einstein College of Medicine of Yeshiva ÈËÆÞÖгöÊÓƵ, also in New York. She completed a residency in General Surgery at Boston ÈËÆÞÖгöÊÓƵ Medical Center in Boston, with an additional fellowship year in oncology research. She is board-certified in General Surgery by the American College of Surgeons and is a member of the American Society of Breast Surgeons.

    Dr. Rosenthal has practiced in Salt Lake City since 1991. She practiced all aspects of General Surgery, including trauma and abdominal surgery, until around 2002, when she began to focus her practice on breast cancer. Her practice has been directed exclusively to treating breast cancer and benign breast disease since that time. She is recognized as an early proponent of the team approach to breast cancer care in Salt Lake City.

    Dr. Rosenthal is able to offer a variety of surgical options depending on individual needs, including sentinel lymph node sampling, skin and nipple-sparing mastectomies, and the use of oncoplastic techniques to improve cosmetic results. She is prepared to incorporate reconstructive surgery approaches together with plastic surgeons as part of overall treatment plans. For many patients, more focused rather than more extensive surgery may be a good option. Cooperative presurgical planning with oncology and radiation oncology professionals can expand the range of choices available to individuals with breast cancer.

    Board Certification and Academic Information

    Academic Departments Surgery -Primary
    Academic Divisions Surgical Oncology
    Board Certification
    American Board of Surgery

    Education history

    Research Fellow Oncology - Boston ÈËÆÞÖгöÊÓƵ Medical Center Research Fellow
    Boston ÈËÆÞÖгöÊÓƵ Administrative Chief Resident
    Residency Boston ÈËÆÞÖгöÊÓƵ Resident
    Boston ÈËÆÞÖгöÊÓƵ Intern
    Professional Medical Medicine - Albert Einstein College of Medicine M.D.
    Biochemistry - City College of New York B.S.

    Selected Publications

    Journal Article

    1. Vaklavas C, Matsen CB, Chu Z, Boucher KM, Scherer SD, Pathi S, Beck A, Brownson KE, Buys SS, Chittoria N, DAstous E, Gulbahce HE, Henry NL, Kimani S, Porretta J, Rosenthal R, Ward J, Wei M, Welm BE, Welm AL (2024). TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer. JCO Precis Oncol, 8, e2300724. ()
    2. Covington MF, Hoffman JM, Morton KA, Buckway B, Boucher KM, Rosenthal R, Porretta J, Brownson KE, Matsen CB, Vaklavas C, Ward JH, Wei M, Buys SS, Chittoria N, Yakish ED, Archibald ZG, Burrell LD, Butterfield RI, Yap JT (2023). Prospective Pilot Study of (18)F-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas. AJR Am J Roentgenol, 221(2), 228-239. ()
    3. Erickson JR, Pahlkotter MK, Thielking PD, Porretta JM, Rosenthal R, Matsen CB, Brownson KE (2023). Leveraging telehealth supportive oncology services to combat COVID-19 isolation in breast cancer patients: A cancer center’s perspective. Patient Exp J, 10(2), 133-137.
    4. Erickson JR, Pahlkotter MK, Thielking PD, Porretta JM, Rosenthal R, Matsen CB, Brownson KE (2023). Leveraging telehealth supportive oncology services to combat COVID-19 isolation in breast cancer patients: A cancer center’s perspective. Patient Exp J, 10(2), 133-137. ()
    5. Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, Toner J, Wang G, Qiao Y, Huang X, Greenland JA, Vahrenkamp JM, Lum DH, Factor RE, Nelson EW, Matsen CB, Poretta JM, Rosenthal R, Beck AC, Buys SS, Vaklavas C, Ward JH, Jensen RL, Jones KB, Li Z, Oesterreich S, Dobrolecki LE, Pathi SS, Woo XY, Berrett KC, Wadsworth ME, Chuang JH, Lewis MT, Marth GT, Gertz J, Varley KE, Welm BE, Welm AL (2022). A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer, 3(2), 232-250. ()

  • News & Podcasts

    Huntsman Cancer Institute News